-
ICD-10-CM Codes
›
-
Q00-Q99
Congenital malformations, deformations and chromosomal abnormalities
›
-
Q80-Q89
Other congenital malformations
›
-
Q86-
Congenital malformation syndromes due to known exogenous causes, not elsewhere classified
›
-
2022 ICD-10-CM Diagnosis Code Q86.2
2022 ICD-10-CM Diagnosis Code Q86.2
Dysmorphism due to warfarin
2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code POA Exempt
- Q86.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2022 edition of ICD-10-CM Q86.2 became effective on October 1, 2021.
- This is the American ICD-10-CM version of Q86.2 - other international versions of ICD-10 Q86.2 may differ.
The following code(s) above
Q86.2 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
Q86.2:
- A rare syndrome characterized by congenital abnormalities caused by fetal exposure to the administration of warfarin to the mother during pregnancy. The congenital abnormalities include nasal bridge depression, nasal bones hypoplasia, microcephaly, congenital heart disorders, and brachydactyly.
- Multiple abnormalities in infants whose mother were treated with coumarin anticoagulants during pregnancy. The most common anomalies include developmental delay, neurological complications (usually hydrocephalus and occasional agenesis of the corpus callosum and meningoencephalocele), midfacial hypoplasia, and various ocular, skeletal, and other defects.
Present On AdmissionPOA Help
"Present On Admission" is defined as present at the time the order for inpatient admission occurs — conditions that develop during an outpatient encounter, including emergency department, observation, or outpatient surgery, are considered POA.
- Q86.2 is considered exempt from POA reporting.
ICD-10-CM Q86.2 is grouped within Diagnostic Related Group(s) (MS-DRG v39.0):
- 794 Neonate with other significant problems
Convert Q86.2 to ICD-9-CM
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
Code annotations containing back-references to Q86.2:
ICD-10-CM Codes Adjacent To Q86.2
Q85.01 Neurofibromatosis, type 1
Q85.02 Neurofibromatosis, type 2
Q85.09 Other neurofibromatosis
Q85.8 Other phakomatoses, not elsewhere classified
Q85.9 Phakomatosis, unspecified
Q86 Congenital malformation syndromes due to known exogenous causes, not elsewhere classified
Q86.0 Fetal alcohol syndrome (dysmorphic)
Q86.1 Fetal hydantoin syndrome
Q86.2
Dysmorphism due to warfarin
Q86.8 Other congenital malformation syndromes due to known exogenous causes
Q87 Other specified congenital malformation syndromes affecting multiple systems
Q87.0 Congenital malformation syndromes predominantly affecting facial appearance
Q87.1 Congenital malformation syndromes predominantly associated with short stature
Q87.19 Other congenital malformation syndromes predominantly associated with short stature
Q87.2 Congenital malformation syndromes predominantly involving limbs
Q87.3 Congenital malformation syndromes involving early overgrowth
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
